Trial Profile
Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 (TPI 1062) After a Single Oral Dose in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2014
Price :
$35
*
At a glance
- Drugs Tianeptine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 08 Feb 2014 New trial record